These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32039380)

  • 1. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis.
    Oo YH; Ackrill S; Cole R; Jenkins L; Anderson P; Jeffery HC; Jones N; Jeffery LE; Lutz P; Wawman RE; Athwal AK; Thompson J; Gray J; Guo K; Barton D; Hirschfield GM; Wong T; Guest P; Adams DH
    JHEP Rep; 2019 Oct; 1(4):286-296. PubMed ID: 32039380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.
    Richardson N; Wootton GE; Bozward AG; Oo YH
    Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
    Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
    J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
    Huang H; Deng Z
    Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis.
    Huang C; Shen Y; Shen M; Fan X; Men R; Ye T; Yang L
    Front Pharmacol; 2021; 12():726128. PubMed ID: 34531750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
    Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
    Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
    Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose interleukin-2 promotes STAT-5 phosphorylation, T
    Jeffery HC; Jeffery LE; Lutz P; Corrigan M; Webb GJ; Hirschfield GM; Adams DH; Oo YH
    Clin Exp Immunol; 2017 Jun; 188(3):394-411. PubMed ID: 28176332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
    Chen J; Liu W; Zhu W
    Med Sci Monit; 2019 Aug; 25():6204-6212. PubMed ID: 31422415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.
    Jeffery HC; Braitch MK; Bagnall C; Hodson J; Jeffery LE; Wawman RE; Wong LL; Birtwistle J; Bartlett H; Lohse AW; Hirschfield GM; Dyson J; Jones D; Hubscher SG; Klenerman P; Adams DH; Oo YH
    Hepatol Commun; 2018 Apr; 2(4):421-436. PubMed ID: 29619420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects
    Reading JL; Roobrouck VD; Hull CM; Becker PD; Beyens J; Valentin-Torres A; Boardman D; Lamperti EN; Stubblefield S; Lombardi G; Deans R; Ting AE; Tree T
    Front Immunol; 2021; 12():716606. PubMed ID: 34539651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proportion of regulatory T cells in peripheral blood of patients with autoimmune hepatitis: A systematic review and meta-analysis.
    Huang Z; Nie S; Wang H; Yan W; Tian D; Liu M
    Int Immunopharmacol; 2023 Sep; 122():110576. PubMed ID: 37390643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35.
    Ulbar F; Villanova I; Giancola R; Baldoni S; Guardalupi F; Fabi B; Olioso P; Capone A; Sola R; Ciardelli S; Del Papa B; Brattelli A; Ricciardi I; Taricani S; Sabbatinelli G; Iuliani O; Passeri C; Sportoletti P; Santarone S; Pierini A; Calabrese G; Falzetti F; Bonfini T; Accorsi P; Ruggeri L; Martelli MF; Velardi A; Di Ianni M
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2204-2210. PubMed ID: 32961369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4
    Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions.
    Hoeppli RE; MacDonald KN; Leclair P; Fung VCW; Mojibian M; Gillies J; Rahavi SMR; Campbell AIM; Gandhi SK; Pesenacker AM; Reid G; Lim CJ; Levings MK
    Am J Transplant; 2019 Jan; 19(1):62-76. PubMed ID: 29766641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.